WALL Street Signals

03/09/2026

Nutriband is continuing its push forward with another important update. https://www.nutriband.com/

01/09/2026

Iveda Solutions Inc. is pursuing a technology opportunity that sits squarely within some of the biggest trends shaping connected infrastructure.

News: https://finance.yahoo.com/technology/ai/articles/iveda-launches-ivedaair-latest-ruas-123000056.html

MESA, Ariz., August 19, 2026--Iveda® (NASDAQ: IVDA), a global leader in AI-powered smart city and public safety technologies, today announced the launch of IvedaAir, their latest line of autonomous unmanned helicopters engineered to deliver real-time aerial intelligence for public safety, maritime,...

30/07/2026

With Virtuix Omni – I just made it onto their weekly engagement list by being one of their top engagers 🎉

24/07/2026

📈 Virtuix Omni is set to report earnings and host a conference call where investors are expecting updates on growth following its Meta launch. Recent milestones include award-winning recognition for its innovations in VR and AI, with technology that could also play a role in the future of humanoid robotics.

🏆 Award details: https://finance.yahoo.com/technology/ai/articles/virtuix-expects-report-major-sales-131700147.html

24/07/2026

| Virtuix Omni (NASDAQ: ) is preparing to share important updates on its growing sales momentum and new partnerships across defense, healthcare, and robotics. A press release will be issued before the conference call.

https://finance.yahoo.com/technology/ai/articles/virtuix-expects-report-major-sales-131700147.html

02/07/2026

📢 Biotech Update

Oncotelic Therapeutics ($OTLC) has published a peer-reviewed manuscript supporting its Deciparticle™ nanoparticle delivery platform, reinforcing the scientific foundation behind Sapu003, its investigational IV everolimus formulation now in a Phase 1b study.

Worth keeping on your biotech watchlist.

https://www.globenewswire.com/news-release/2026/06/29/3318946/0/en/oncotelic-announces-peer-reviewed-validation-of-deciparticle-platform-supporting-clinical-development-of-sapu003.html

Charles DAvanzo